Home  >  Health Check  >  Covid-19 vaccines: Unknowns and dilemmas
Health Check
Covid-19 vaccines: Unknowns and dilemmas
Health Check
Nov 4, 2020

Some of the first large scale trials of Covid-19 vaccines may report results to regulators in the next few weeks. These first results will reveal how effective these vaccines are at preventing mild Covid illness but they’re unlikely to tell us how good they are at preventing serious disease and death. Should governments permit wide scale vaccination of populations based on that level of data when this may compromise learning more about their efficacy? And might widespread deployment of first generation Covid-19 vaccines make it harder to properly trial vaccines at earlier stages of development but which may have the potential to be more effective? Claudia Hammond discusses the dilemmas with Dr Gregory Poland, director of the Mayo Vaccine Research Group.

People who are double-jointed are much more prone to suffering from anxiety and panics attacks. Reporter Madeleine Finlay investigates the link.

Claudia consults mental health experts for tips to help people get through the coming months of uncertainty and anxiety.

Boston University epidemiologist Matthew Fox joins Claudia with insights on vaccine hesitancy, how Namibia is maintaining its HIV treatment services under Covid-19 restrictions and whether antibiotics can prevent surgery for appendicitis.

Presenter: Claudia Hammond Producer: Andrew Luck-Baker

(Picture: A doctor preparing a coronavirus vaccine. Photo credit: Filippo Bacci/Getty Images.)

More Episodes


Mar 25, 2026
Antimicrobial resistance in conflict zones

For the last few weeks, the news has been dominated by the situation in the Middle East. Joining Claudia Hammond is BBC Health Correspondent James Gallagher who speaks with Dr Antoine Abou Fayad, a microbiologist and medicinal chemist based in Beirut, Lebanon. He reveals that war, just like the ongoing conflict in the Middle East, provides the perfect storm to accelerate the spread of multidrug-resistant infections. And nobody is safe.

Following the recent meningitis B outbreak in the UK which has killed two people and led to the rollout of vaccines and preventative antibiotics, Claudia and James discuss how meningitis outbreaks are dealt with in the ‘meningitis belt’ - an area stretching across 26 sub-Saharan African countries and talk about a new vaccine aiming to stop deadly meningitis epidemics which has been confirmed to be safe following analysis of vaccination campaigns in Nigeria and Niger.

And India's snakebite crisis is killing near sixty thousand people every year, about six people every hour. Journalist Chhavi Sachdev joins us to discuss the progress of India’s National Action Plan to tackle snakebite envenoming which launched two years ago. Also, what time of day do you exercise? Well, a new study using Fitbit-derived heart rate data has found that people who regularly exercised early in the morning were significantly less likely to have coronary artery disease, high blood pressure, Type 2 diabetes or obesity compared with people who exercised later in the day.

Presenter: Claudia Hammond Producer: Jonathan Blackwell


26min 28sec

Mar 18, 2026
Does your home country impact your cancer risk?

North Korean defectors and lifelong South Korean residents have significantly different cancer rates, despite their genetic similarities; new research finds. Presenter Laura Foster unpacks this study, explaining what it tells us about how upbringing and environment contribute to different cancer rates, and how migration can change these risks.

A new study has found GLP-1s – drugs typically used to treat diabetes and obesity – could have an unexpected benefit for patients dealing with substance abuse disorders. Laura speaks with Ziyad Al-Aly, a clinical epidemiologist and Veterans Affairs physician at Washington University in St Louis to understand what this could mean for treating drug and alcohol addictions, and what questions still need answers before this treatment can be rolled out.

Last weekend, Kenya’s National Environment Management Authority rolled out new waste management rules to better dispose of products containing plastic, but the new laws are expected to increase the price of sanitary pads by 20%. Global health reporter based in Nairobi, Dorcas Wangira joins Laura to unpack what these policies mean for the accessibility of sanitary products, and what alternative solutions are needed to balance access with environmental impact. They also discuss how a drug to treat Parkinson’s disease can be made from waste plastic bottles using a pioneering method.

And Jane Chambers reports from Peru about the growing prevalence of anaemia, speaking to local healthcare workers about what steps families can be taken to help their children recover.

Presenter: Laura Foster Producers: Jonathan Blackwell and Georgia Christie


26min 28sec

Covid-19 vaccines: Unknowns and dilemmas

--:--
--:--